查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2021561

全球神经回馈设备市场预测（至2034年）：按类型、应用、最终用户和地区划分

Neurofeedback Devices Market Forecasts to 2034- Global Analysis By Type (EEG Neurofeedback Devices, fNIRS Neurofeedback Devices, HEG Neurofeedback Devices and Other Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计到 2026 年，全球神经反馈设备市场规模将达到 15.4 亿美元，在预测期内以 7.3% 的复合年增长率增长，到 2034 年将达到 27.1 亿美元。

神经回馈设备是一种先进的治疗系统，它透过监测和分析脑电波活动并提供即时回馈，来支持神经功能的自我调节。这些设备利用脑电图（EEG）感测器捕捉大脑的电讯号，并将其转化为视觉、听觉或触觉提示。透过强化理想的脑电图模式并抑制异常活动，神经回馈有助于改善认知功能、情绪稳定性和行为表现。这些设备广泛应用于注意力不足过动症（ADHD）、焦虑症和睡眠障碍等疾病的治疗，并越来越多地应用于临床、研究机构和家庭，作为一种非侵入性、无药物的干预手段来优化神经功能。

神经系统负担加重和精神疾病

神经系统和精神疾病（包括注意力不足过动症、焦虑症、忧郁症和失眠）的日益普遍，显着地推动了对神经回馈设备的需求。人们对非侵入性、无药物治疗方法方案的认识不断提高，促使患者和医疗保健提供者都开始采用神经回馈疗法。此外，压力水平的上升、都市生活方式的改变以及诊断能力的提高，也促进了诊断率的提升。不断扩大的患者群体，以及个人化和预防性医疗的兴起，持续推动全球市场的成长。

设备和治疗高成本

神经回馈设备和治疗疗程的高成本仍然是限制市场扩张的主要因素。先进的脑电图（EEG）系统需要复杂的硬体、软体整合和专业知识，这都推高了其价格。此外，通常需要多次治疗才能达到预期效果，这增加了患者的总治疗成本。许多地区的保险覆盖范围和报销政策的限制也阻碍了神经回馈技术的普及。这些经济障碍对开发中国家神经回馈技术的普及影响尤其显着。

脑监测技术的进步

脑监测技术的持续进步为市场带来了巨大的机会。穿戴式脑电图系统、人工智慧和即时数据分析的创新正在提升设备的精准度、易用性和患者舒适度。与行动应用和云端平台的整合实现了远端监测和个人化治疗，使患者能够在临床环境之外获得治疗。这些进步正在加速家庭神经反馈解决方案的出现，减少对医疗机构的依赖，并为製造商和服务供应商开闢新的成长途径。

监管障碍和核准延误

严格的监管要求和冗长的核准流程对市场构成重大威胁。医疗设备的监管规定因地区而异，需要大量的临床检验、安全评估和合规性文件准备。这些流程可能会延迟产品上市，并增加製造商的研发成本。此外，神经回馈疗法缺乏标准化方案，引发了人们对其疗效和一致性的担忧。这些复杂的监管规定对新进入者构成威胁，并可能扼杀创新，最终限制市场整体扩张的速度。

新型冠状病毒（COVID-19）的影响：

新冠疫情对市场产生了复杂的影响。初期，供应链中断和门诊就诊量下降阻碍了设备的普及，而疫情期间人们对心理健康的关注度提升则创造了新的机会。焦虑、压力和睡眠障碍病例的增加推动了对非侵入性治疗方案的需求。此外，远端保健和远距照护的兴起也加速了家用神经回馈系统的普及。这项转变凸显了数位健康技术的重要性，并支撑着市场长期成长，儘管短期内面临许多挑战。

在预测期内，HEG神经反馈设备细分市场预计将占据最大的市场份额。

由于与传统的基于脑电图（EEG）的系统相比，HEG神经反馈设备具有成本效益高、易于使用等优点，预计在预测期内，HEG神经反馈设备将占据最大的市场份额。 HEG设备测量大脑的血流和氧合情况，为神经回馈疗法提供了一种更简单、更方便的方法。认知训练、压力管理和教育等领域的广泛应用正在推动这一细分市场的成长。此外，技术复杂性的降低和家庭应用的增加也进一步促进了其普及。

预计在预测期内，癫痫领域将呈现最高的复合年增长率。

在预测期内，癫痫领域预计将呈现最高的成长率，这主要受癫痫发作性疾病盛行率上升以及对非药物治疗方案需求日益增长的推动。神经回馈疗法透过调节与癫痫相关的异常脑电图活动，降低部分患者的癫痫发作频率，展现出良好的疗效。医护人员和患者对替代疗法的认知不断提高，推动了神经回馈疗法的应用。此外，正在进行的研究和临床试验检验了神经回馈疗法在癫痫治疗中的有效性，预计这将进一步加速该领域的成长。

市占率最大的地区：

在预测期内，亚太地区预计将占据最大的市场份额，这主要得益于人们对心理健康意识的提高以及医疗基础设施的改善。快速的都市化和压力相关疾病的增加，推动了对神经反馈疗法的需求成长。此外，医疗技术投资的增加、私人医疗机构的扩张以及政府的支持措施，也都在推动市场成长。新兴经济体中价格适中的设备和服务的日益普及，进一步巩固了该地区的优势。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于医疗保健支出不断增长以及先进治疗方案的普及。数位健康平台的日益普及和家用神经回馈系统接受度的提高将是关键的成长要素。此外，对早期诊断和预防医学的高度重视，以及大规模人群，都创造了巨大的成长机会。主要企业的持续创新和不断增加的投资，正在进一步加速该地区的市场扩张。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域划分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 促进因素、挑战和机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管/政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球神经回馈设备市场：按类型划分

  • 脑电图神经回馈装置
  • fNIRS神经回馈装置
  • HEG神经回馈装置
  • 其他类型

第六章 全球神经回馈设备市场：依应用划分

  • 注意力不足过动症（ADHD）
  • 焦虑症
  • 忧郁症
  • 癫痫
  • 泛自闭症障碍
  • 睡眠障碍
  • 其他用途

第七章 全球神经回馈设备市场：依最终用户划分

  • 医院和诊所
  • 研究和学术机构
  • 家
  • 其他最终用户

第八章 全球神经回馈设备市场：按地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第九章 战略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十章：产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟、合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十一章：公司简介

  • BrainMaster Technologies, Inc.
  • Thought Technology Ltd.
  • Mind Media BV
  • NeuroSky, Inc.
  • Emotiv Inc.
  • Neuroelectrics Corporation
  • Mitsar Co. Ltd.
  • BEE Medic GmbH
  • Myndlift Ltd.
  • Muse（InteraXon Inc.）
  • Wearable Sensing
  • NeuroCare Group GmbH
  • ANT Neuro bv
  • Advanced Brain Monitoring, Inc.
  • BrainCo, Inc.
Product Code: SMRC34901

According to Stratistics MRC, the Global Neurofeedback Devices Market is accounted for $1.54 billion in 2026 and is expected to reach $2.71 billion by 2034 growing at a CAGR of 7.3% during the forecast period. Neurofeedback devices are advanced therapeutic systems that monitor, analyze, and provide real-time feedback on brainwave activity to support self-regulation of neural function. Utilizing electroencephalography (EEG) sensors, these devices capture electrical signals from the brain and translate them into visual, auditory, or tactile cues. By reinforcing desirable brainwave patterns and discouraging irregular activity, neurofeedback aids in improving cognitive performance, emotional stability, and behavioral outcomes. Commonly applied in conditions such as ADHD, anxiety, and sleep disorders, these devices are increasingly used in clinical, research, and home settings as a non-invasive, drug free intervention for neurological optimization.

Market Dynamics:

Driver:

Rising burden of neurological and mental health disorders

The growing prevalence of neurological and mental health conditions, including ADHD, anxiety, depression, and insomnia, is significantly driving demand for neurofeedback devices. Increasing awareness of non-invasive and drug-free treatment alternatives has encouraged both patients and healthcare providers to adopt neurofeedback therapies. Additionally, rising stress levels, urban lifestyles, and improved diagnostic capabilities are contributing to higher diagnosis rates. This expanding patient pool, combined with a shift toward personalized and preventive care, continues to strengthen market growth globally.

Restraint:

High cost of devices and therapy

The high cost associated with neurofeedback devices and therapy sessions remains a key restraint for market expansion. Advanced EEG-based systems require sophisticated hardware, software integration, and professional expertise, leading to elevated pricing. Furthermore, multiple therapy sessions are often needed to achieve desired outcomes, increasing the overall treatment cost for patients. Limited insurance coverage and reimbursement policies in many regions further restrict accessibility. These financial barriers particularly impact adoption in developing economies.

Opportunity:

Technological advancements in brain monitoring

Continuous advancements in brain monitoring technologies present significant opportunities for the market. Innovations in wearable EEG systems, artificial intelligence, and real-time data analytics are enhancing device accuracy, usability, and patient comfort. The integration of mobile applications and cloud-based platforms enables remote monitoring and personalized therapy, expanding access beyond clinical settings. These developments are fostering the emergence of home-based neurofeedback solutions, reducing dependency on healthcare facilities and creating new growth avenues for manufacturers and service providers.

Threat:

Regulatory hurdles and approval delays

Stringent regulatory requirements and prolonged approval timelines pose a major threat to the market. Medical device regulations vary across regions, requiring extensive clinical validation, safety assessments, and compliance documentation. These processes can delay product launches and increase development costs for manufacturers. Additionally, the lack of standardized protocols for neurofeedback therapy raises concerns regarding efficacy and consistency. Such regulatory complexities may discourage new entrants and slow innovation, thereby limiting the overall pace of market expansion.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While initial disruptions in supply chains and reduced clinical visits hindered device adoption, the growing focus on mental health during the pandemic created new opportunities. Increased cases of anxiety, stress, and sleep disorders drove demand for non-invasive therapeutic solutions. Additionally, the shift toward telehealth and remote care accelerated the adoption of home-based neurofeedback systems. This transition highlighted the importance of digital health technologies, supporting long term market growth despite short term challenges.

The HEG neurofeedback devices segment is expected to be the largest during the forecast period

The HEG neurofeedback devices segment is expected to account for the largest market share during the forecast period, due to its cost effectiveness and ease of use compared to traditional EEG-based systems. HEG devices measure blood flow and oxygenation in the brain, offering a simpler and more accessible approach to neurofeedback therapy. Their growing adoption in cognitive training, stress management, and educational settings is driving segment growth. Additionally, reduced technical complexity and increasing availability in home based applications further contribute to their widespread utilization.

The epilepsy segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the epilepsy segment is predicted to witness the highest growth rate, due to increasing prevalence of seizure disorders and the need for non-pharmacological treatment options. Neurofeedback therapy offers promising benefits in regulating abnormal brainwave activity associated with epilepsy, reducing seizure frequency in some patients. Growing awareness among healthcare professionals and patients regarding alternative therapies is supporting adoption. Furthermore, ongoing research and clinical studies validating neurofeedback efficacy in epilepsy management are expected to accelerate growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising awareness of mental health, and improving healthcare infrastructure. Rapid urbanization and increasing stress-related disorders are contributing to higher demand for neurofeedback therapies. Additionally, growing investments in healthcare technology, expanding private healthcare facilities, and supportive government initiatives are fostering market growth. The increasing availability of affordable devices and services in emerging economies further strengthens the region's dominant position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing healthcare expenditure, and expanding access to advanced treatment solutions. The rising penetration of digital health platforms and growing acceptance of home-based neurofeedback systems are key growth drivers. Additionally, a strong focus on early diagnosis and preventive healthcare, coupled with a large underserved population, creates significant growth opportunities. Continuous innovation and increasing investments by global and regional players further accelerate market expansion in the region.

Key players in the market

Some of the key players in Neurofeedback Devices Market include BrainMaster Technologies, Inc., Thought Technology Ltd., Mind Media B.V., NeuroSky, Inc., Emotiv Inc., Neuroelectrics Corporation, Mitsar Co. Ltd., BEE Medic GmbH, Myndlift Ltd., Muse (InteraXon Inc.), Wearable Sensing, NeuroCare Group GmbH, ANT Neuro B.V., Advanced Brain Monitoring, Inc. and BrainCo, Inc.

Key Developments:

In October 2025, Inception partnered with Brain Co. to co-develop scalable and explainable AI products for enterprises, combining applied research with advanced AI platforms. The collaboration focuses on sectors like healthcare, energy, and public services, delivering trusted, high-impact solutions that enhance decision-making and operational efficiency.

In January 2025, Neuro XR (NXR) partnered with Emotiv to launch emotional heat-mapping technology that combines advanced analytics with EEG data. The solution delivers real-time insights into user emotions, integrating eye-tracking and movement mapping to enhance decision-making, product design, training effectiveness, and audience engagement across industries.

Types Covered:

  • EEG Neurofeedback Devices
  • fNIRS Neurofeedback Devices
  • HEG Neurofeedback Devices
  • Other Types

Applications Covered:

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Anxiety Disorders
  • Depression
  • Epilepsy
  • Autism Spectrum Disorders
  • Sleep Disorders
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Research & Academic Institutes
  • Home Use
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Neurofeedback Devices Market, By Type

  • 5.1 EEG Neurofeedback Devices
  • 5.2 fNIRS Neurofeedback Devices
  • 5.3 HEG Neurofeedback Devices
  • 5.4 Other Types

6 Global Neurofeedback Devices Market, By Application

  • 6.1 Attention Deficit Hyperactivity Disorder (ADHD)
  • 6.2 Anxiety Disorders
  • 6.3 Depression
  • 6.4 Epilepsy
  • 6.5 Autism Spectrum Disorders
  • 6.6 Sleep Disorders
  • 6.7 Other Applications

7 Global Neurofeedback Devices Market, By End User

  • 7.1 Hospitals & Clinics
  • 7.2 Research & Academic Institutes
  • 7.3 Home Use
  • 7.4 Other End Users

8 Global Neurofeedback Devices Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 BrainMaster Technologies, Inc.
  • 11.2 Thought Technology Ltd.
  • 11.3 Mind Media B.V.
  • 11.4 NeuroSky, Inc.
  • 11.5 Emotiv Inc.
  • 11.6 Neuroelectrics Corporation
  • 11.7 Mitsar Co. Ltd.
  • 11.8 BEE Medic GmbH
  • 11.9 Myndlift Ltd.
  • 11.10 Muse (InteraXon Inc.)
  • 11.11 Wearable Sensing
  • 11.12 NeuroCare Group GmbH
  • 11.13 ANT Neuro b.v.
  • 11.14 Advanced Brain Monitoring, Inc.
  • 11.15 BrainCo, Inc.

List of Tables

  • Table 1 Global Neurofeedback Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Neurofeedback Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Neurofeedback Devices Market Outlook, By EEG Neurofeedback Devices (2023-2034) ($MN)
  • Table 4 Global Neurofeedback Devices Market Outlook, By fNIRS Neurofeedback Devices (2023-2034) ($MN)
  • Table 5 Global Neurofeedback Devices Market Outlook, By HEG Neurofeedback Devices (2023-2034) ($MN)
  • Table 6 Global Neurofeedback Devices Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 7 Global Neurofeedback Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 8 Global Neurofeedback Devices Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2023-2034) ($MN)
  • Table 9 Global Neurofeedback Devices Market Outlook, By Anxiety Disorders (2023-2034) ($MN)
  • Table 10 Global Neurofeedback Devices Market Outlook, By Depression (2023-2034) ($MN)
  • Table 11 Global Neurofeedback Devices Market Outlook, By Epilepsy (2023-2034) ($MN)
  • Table 12 Global Neurofeedback Devices Market Outlook, By Autism Spectrum Disorders (2023-2034) ($MN)
  • Table 13 Global Neurofeedback Devices Market Outlook, By Sleep Disorders (2023-2034) ($MN)
  • Table 14 Global Neurofeedback Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 15 Global Neurofeedback Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 16 Global Neurofeedback Devices Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 17 Global Neurofeedback Devices Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 18 Global Neurofeedback Devices Market Outlook, By Home Use (2023-2034) ($MN)
  • Table 19 Global Neurofeedback Devices Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.